Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Nepnieuws van Amar/Esperite
Volgen
Company press releases Displaying 21 - 40 of 110 results Released Company Title Industry Topic 01 Jul 2019 07:17 CEST ESPERITE ESPERITE NV (ESP) AVEC CRYOSAVE CONFIRME LA SÉCURITÉ DE TOUS LES ÉCHANTILLONS STOCKÉS ET REMERCIE LES 260'000 FAMILLES POUR LEUR CONFIANCE. Biotechnology Alliances and agreements 30 Jun 2019 21:01 CEST ESPERITE ESPERITE N.V. (ESP) publishes its half-year report. Revenues, results and consolidated equity were impacted by adverse market conditions on the stem cell business. Biotechnology New 28 Jun 2019 23:51 CEST ESPERITE Esperite N.V.: Update to the market on the publication of the Annual Report 2018 Biotechnology New 25 Jun 2019 22:59 CEST ESPERITE ESPERITE (ESP) announces termination of negotiations regarding proposed sale of stem cell banking business to PBKM Biotechnology Other subject 14 Jun 2019 08:54 CEST ESPERITE ESPERITE (ESP) negotiates 18-month extension for EUR 4,750,000 in unsecured convertible loan notes Biotechnology Other subject 13 Jun 2019 07:17 CEST ESPERITE ESPERITE (ESP) resumes negotiations regarding proposed sale of stem cell banking business to PBKM Biotechnology Other subject 04 Jun 2019 10:18 CEST ESPERITE Esperite NV (ESP) introduces Jouvene - Swiss Medicine Quintessence, the first combined offer of Stem Cell long term storage and highly accurate Whole Genome Sequencing for Consumer distribution. Biotechnology Other subject 29 May 2019 08:26 CEST ESPERITE ESPERITE (ESP) announces termination of MoU regarding proposed sale of stem cell banking business to PBKM due to lack of agreement on the terms of the sale Biotechnology Other subject 19 May 2019 22:54 CEST ESPERITE ESPERITE (ESP) announces listing measure by Euronext due to delay in publication of its 2018 annual report (as announced on 30 April 2019) Biotechnology Other subject 13 May 2019 07:17 CEST ESPERITE Esperite N.V. (ESP) : Update to the market on the publica-tion of the Annual Report 2018 and The Cell Factory cur-rent configuration. Biotechnology Other subject 01 May 2019 16:58 CEST ESPERITE Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2018 Biotechnology Other subject 05 Apr 2019 07:17 CEST ESPERITE ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund Biotechnology Other subject 27 Feb 2019 07:17 CET ESPERITE Esperite N.V. (ESP) with The Cell Factory has confirmed a long-term effect of extracellular vesicle drug candidate CF-MEV-132 for the treatment of Bronchopulmonary Dysplasia. Biotechnology Other subject 26 Feb 2019 07:17 CET ESPERITE ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund Biotechnology Other subject 22 Feb 2019 07:17 CET ESPERITE ESPERITE NV (ESP) AND PBKM (FAMICORD GROUP) SIGN EXCLUSIVE AGREEMENT REGARDING POTENTIAL ACQUISITION OF CRYO-SAVE’S FAMILY STEM CELL BANKING BUSINESS. Biotechnology Other subject 10 Jan 2019 07:17 CET ESPERITE ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 24th tranche of investment today Biotechnology Other subject 30 Nov 2018 07:17 CET ESPERITE ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 23rd tranche of investment today Biotechnology Other subject 29 Nov 2018 07:17 CET ESPERITE Esperite (ESP) with The Cell Factory, prepares to raise series A round of investments to continue its clinical program testing Extracellular Vesicles drug candidates. Biotechnology Other subject 27 Nov 2018 18:26 CET ESPERITE ESPERITE N.V. convenes Annual General Meeting of Shareholders Biotechnology Other subject 23 Nov 2018 23:35 CET ESPERITE ESPERITE (ESP): financial results for 2017 are published. Biotechnology Other subject
Met nepnieuws bedoel ik nieuws wat bedoelt is om de aandeelhouders te misleiden.
Company press releases Displaying 41 - 60 of 110 results Released Company Title Industry Topic 19 Nov 2018 15:35 CET ESPERITE ESPERITE (ESP) announces publication of its Annual Report 2017 before 24 November 2018 Biotechnology Other subject 09 Nov 2018 07:17 CET ESPERITE ESPERITE (ESP) expects publication of Annual Report 2017 before 17 November 2018 Biotechnology Other subject 07 Nov 2018 07:17 CET ESPERITE Esperite Group with The Cell Factory, expands its patent portfolio on extra-cellular vesicles biologic drugs in Canada. Biotechnology Other subject 06 Nov 2018 08:56 CET ESPERITE Esperite Group with The Cell Factory expands its Extracellular Vesicles product portfolio of anti-inflammatory drugs with a fourth indication : Bronchopulmonary Dysplasia. Biotechnology Other subject 15 Oct 2018 07:17 CEST ESPERITE ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 22nd tranche of investment today Biotechnology Other subject 03 Oct 2018 18:18 CEST ESPERITE Esperite N.V. (ESP): Sale by Esperite of stake in Cryo-Save South Africa cancelled Biotechnology Other subject 13 Sep 2018 07:17 CEST ESPERITE ESPERITE N.V. (ESP) WITH CRYOSAVE READY TO STORE MORE THAN A MILLION SAMPLES IN ITS NEW DESIGNED CRYOSTORAGE FACILITY IN GENEVA. Biotechnology Other subject 31 Aug 2018 07:17 CEST ESPERITE Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2017. Biotechnology Other subject 29 Aug 2018 07:17 CEST ESPERITE ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 21st tranche of investment today Biotechnology Other subject 15 Aug 2018 07:17 CEST ESPERITE Esperite N.V. (ESP) : Update on the publication of the Annual Report 2017. Biotechnology Other subject 18 Jul 2018 08:26 CEST ESPERITE Esperite N.V. (ESP) : Additional delays needed on the publication of the Annual Report 2017 Biotechnology Other subject 02 Jul 2018 07:17 CEST ESPERITE ESPERITE N.V. (ESP) SELLS ITS STAKE IN CRYOSAVE SOUTH AFRICA TO GO LIFE HEALTHCARE (GLI). Biotechnology Other subject 28 Jun 2018 07:17 CEST ESPERITE ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 20th tranche of investment today Biotechnology Other subject 19 Jun 2018 07:17 CEST ESPERITE Esperite N.V. secures external financing of up to EUR 5 million to support its commercial activity and development of innovative technologies Biotechnology Other subject 18 Jun 2018 22:24 CEST ESPERITE ESPERITE (ESP) further delays publication of Annual Report 2017. Biotechnology Other subject 12 Jun 2018 07:17 CEST ESPERITE European Select Growth Opportunities Fund subscribes to the 19th tranche of its investment today and has agreed to provide up to EUR 7.25 million in additional funding Biotechnology Other subject 06 Jun 2018 08:26 CEST ESPERITE ESPERITE NV (ESP) LAUNCHS NEW AGAATA Dx, DIAGNOSTIC SYSTEM WITH MACHINE LEARNING CAPABILITIES FOR GENETIC CLINICAL LABORATORIES. Biotechnology Other subject 05 Jun 2018 07:17 CEST ESPERITE ESPERITE (ESP) expects publication of Annual Report 2017 before 18 June 2018 Biotechnology Other subject 17 May 2018 14:33 CEST ESPERITE Esperite NV (ESP) with The Cell Factory has signed the agreement with the PHARM CRO to start preparation for the first-in-man clinical trials in treatment of Crohn's disease. Biotechnology Other subject 17 May 2018 07:17 CEST ESPERITE ESPERITE (ESP) : L1 Capital subscribes to the 18th tranche of investment today Biotechnology Other subject
Company press releases Displaying 61 - 80 of 110 results Released Company Title Industry Topic 16 May 2018 09:31 CEST ESPERITE ESPERITE NV (ESP) WITH CRYOSAVE TAKES OVER FULL CONTROL OF BUSINESS IN SOUTH AFRICA AND INTEND TO DISTRIBUTE ADVANCED SERVICES TO THE GROWING AFRICAN POPULATION Biotechnology Other subject 03 May 2018 11:36 CEST ESPERITE Esperite's (ESP) The Cell Factory received European funding to develop the 2nd generation EVs drug for treatment of Stroke Biotechnology Other subject 30 Apr 2018 12:55 CEST ESPERITE ESPERITE NV (ESP) delays publication of Annual Report 2017 Biotechnology Other subject 11 Apr 2018 07:17 CEST ESPERITE ESPERITE (ESP): EUR 1,200,000 of new funding provided by European Select Growth Opportunities Fund until May 25, 2018. Biotechnology Other subject 29 Mar 2018 09:15 CEST ESPERITE Esperite (ESP), The Cell Factory presents pre-clinical results on the new products of the 2nd generation EV's drugs for treatment of inflammatory diseases Biotechnology Other subject 02 Mar 2018 07:17 CET ESPERITE ESPERITE (ESP) : L1 Capital subscribes to the 16th tranche of investment today Biotechnology Other subject 16 Feb 2018 07:17 CET ESPERITE ESPERITE (ESP): EUR 500,000 of new funding provided by European Select Growth Opportunities Fund until March 2, 2018. Biotechnology Other subject 31 Jan 2018 13:26 CET ESPERITE ESPERITE (ESP) and BGI Genomics (BGI) sign a strategic agreement to offer Whole Genome Sequencing on a large scale. Biotechnology Other subject 31 Jan 2018 07:17 CET ESPERITE ESPERITE (ESP) : L1 Capital subscribes to the 14th tranche of investment today Biotechnology Other subject 16 Jan 2018 07:17 CET ESPERITE ESPERITE (ESP) : L1 Capital subscribes to the 13th tranche of investment today Biotechnology Other subject 10 Jan 2018 15:07 CET ESPERITE ESPERITE (ESP) : transfers its laboratory activity to Geneva and consequently sells its Belgium loss making subsidiary and avoids EUR 4 millions of future cash out for charges and financial costs Biotechnology Other subject 10 Jan 2018 07:17 CET ESPERITE ESPERITE (ESP) : L1 Capital subscribes to the 12th tranche of investment today Biotechnology Other subject 08 Jan 2018 12:59 CET ESPERITE ESPERITE (ESP): CEO Frederic Amar converts a portion of his Loan Note into 1.5 million shares. Biotechnology Other subject 05 Jan 2018 10:56 CET ESPERITE ESPERITE (ESP): issues EUR 400'000 convertible note for additional financing provided by CEO Frederic Amar Biotechnology Other subject 22 Dec 2017 07:17 CET ESPERITE ESPERITE (ESP): EUR 1 million of new funding provided by European Select Growth Opportunities Fund until February 23, 2018 Biotechnology Other subject 17 Nov 2017 08:19 CET ESPERITE ESPERITE N.V. (ESP) , Stabilisation before growth. Biotechnology Other subject 09 Nov 2017 08:54 CET ESPERITE ESPERITE (ESP) : L1 Capital invests for total EUR 500K today by subscribing to the Tenth tranche (EUR 250K) and shows confidence by investing additionally EUR 250K under the same conditions. Biotechnology Other subject 09 Nov 2017 07:17 CET ESPERITE ESPERITE (ESP) : L1 Capital subscribes to the Tenth tranche of investment today and shows confidence by investing additionally EUR 250K under the same conditions. Biotechnology Other subject 30 Oct 2017 07:17 CET ESPERITE ESPERITE (ESP) : L1 Capital subscribes to the Ninth tranche of investment today Biotechnology Other subject 10 Oct 2017 08:52 CEST ESPERITE ESPERITE (ESP) : EUR 1.1 million of new funding provided by L1 Capital to support Esperite's strategy, commercial activities and development of innovative technologies Biotechnology Other subject
Company press releases Displaying 81 - 100 of 110 results Released Company Title Industry Topic 10 Oct 2017 07:17 CEST ESPERITE ESPERITE (ESP) : EUR 1.1 million of new funding provided by L1 Capital to support Esperite's strategy, commercial activities and development of innovative technologies Biotechnology Other subject 02 Oct 2017 07:17 CEST ESPERITE ESPERITE N.V. (ESP) publishes its half-year report. Revenues and results were unexpectedly impacted by pending legal actions. Biotechnology Other subject 29 Sep 2017 21:16 CEST ESPERITE ESPERITE N.V. (ESP) delays publication of 2017 Interim Financial Reporting Biotechnology Other subject 31 Aug 2017 07:17 CEST ESPERITE ESPERITE (ESP): L1 Capital subscribes to the Seventh tranche of investment today Biotechnology Other subject 11 Aug 2017 07:17 CEST ESPERITE ESPERITE (ESP): L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 0.6 million before August 31, 2017 Biotechnology Other subject 05 Jul 2017 07:17 CEST ESPERITE ESPERITE (ESP): L1 Capital subscribes to the fourth packed tranche of investment today Biotechnology Other subject 15 Jun 2017 07:17 CEST ESPERITE ESPERITE (ESP): L1 Capital subscribes to the third packed tranche of investment today Biotechnology Other subject 01 Jun 2017 07:17 CEST ESPERITE ESPERITE (ESP): L1 Capital subscribes to the second packed tranche today, ahead of schedule Biotechnology Other subject 31 May 2017 08:52 CEST ESPERITE ESPERITE (ESP) : L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 1.1 million before July 12, 2017 Biotechnology Other subject 31 May 2017 08:26 CEST ESPERITE ESPERITE (ESP) : L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 1.1 million before July 12, 2017 Biotechnology Other subject 31 May 2017 07:57 CEST ESPERITE ESPERITE (ESP) Q1 consolidated revenue higher compared to budget Biotechnology Other subject 31 May 2017 07:17 CEST ESPERITE ESPERITE (ESP) has concluded new agreements with its note holders Biotechnology Other subject 23 May 2017 15:44 CEST ESPERITE ESPERITE N.V. convenes Annual General Meeting of Shareholders Biotechnology Other subject 23 May 2017 07:17 CEST ESPERITE ESPERITE (ESP) financial results for 2016 published Biotechnology Other subject 20 May 2017 18:28 CEST ESPERITE Esperite further delays publication of 2016 Annual Report Biotechnology Other subject 19 May 2017 13:20 CEST ESPERITE Esperite (ESP) announces that Genoma SA filed appeal to the decision ruled by the Swiss Court Biotechnology Other subject 15 May 2017 10:17 CEST ESPERITE Esperite (ESP) - Esperite confirms the positive development of its current and future genetic activities and announces its intentions to claim 5.2 Million euro damages against Premaitha (NIPT) Biotechnology Other subject 15 May 2017 10:17 CEST ESPERITE Esperite (ESP) confirme le développement positif de ses activités génétiques et annonce son intention de réclamer 5,2 millions de dommages-intérêts à Premaitha (NIPT) Biotechnology Other subject 15 May 2017 07:17 CEST ESPERITE Esperite (ESP) confirme le développement positif de ses activités génétiques et annonce son intention de réclamer 5,2 millions de dommages-intérêts à Premaitha (NIPT) Biotechnology Other subject 15 May 2017 07:17 CEST ESPERITE Esperite (ESP) - Esperite confirms the positive development of its current and future genetic activities and announces its intentions to claim 5.2 Million euro damages against Premaitha (NIPT) Biotechnology Other subject
Company press releases Displaying 101 - 110 of 110 results Released Company Title Industry Topic 11 May 2017 09:27 CEST ESPERITE Esperite (ESP): Patent granted in China for treatment of acute and chronic inflammatory and autoimmune diseases with EVs technology Biotechnology Other subject 05 May 2017 09:08 CEST ESPERITE Esperite (ESP), The Cell Factory demonstrate anti-inflammatory mode of action of CF-MEV-117 extracellular vesicle drug candidate for Epilepsy Biotechnology Other subject 26 Apr 2017 07:17 CEST ESPERITE ESPERITE delays publication of 2016 Annual Report Biotechnology Other subject 25 Apr 2017 07:17 CEST ESPERITE ESPERITE N.V. (ESP) WITH CRYOSAVE CONTRIBUTES TO TREATING A 9 YEAR OLD CHILD WITH THALASSEMIA MAJOR IN SWITZERLAND Biotechnology Other subject 24 Apr 2017 07:17 CEST ESPERITE ESPERITE's shareholders approved the external financing of up to EUR 13 million Biotechnology Other subject 31 Mar 2017 22:06 CEST ESPERITE CryoSave e Crioestaminal chegaram a um acordo para a armazenagem das células estaminais da Bioteca Biotechnology Other subject 10 Mar 2017 14:29 CET ESPERITE Esperite N.V. convenes Extraordinary General Meeting of Shareholders regarding external financing of up to EUR 13 million Biotechnology Other subject 08 Mar 2017 08:26 CET ESPERITE Esperite secures external financing of up to EUR 9 million to support its commercial activity and development of innovative technologies Biotechnology Other subject 08 Mar 2017 07:17 CET ESPERITE Esperite secures external financing of up to EUR 9 million to support its commercial activity and development of innovative technologies Biotechnology Other subject 28 Feb 2017 08:55 CET ESPERITE Esperite N.V.: Update on Financing Biotechnology Other subject
Dat jij de moeite neemt om al die ouwe shit uit de put op te dreggenn
Amarillo schreef op 5 augustus 2020 15:13 :
Dat jij de moeite neemt om al die ouwe shit uit de put op te dreggenn
Slimme mensen leren van het verleden. Iemand die deze berichten goed leest begrijpt dat hij wordt opgelicht. Ik wil newbies een eerlijke kans geven om hun geld al dan niet weg te gooien.
Je weet wat ik gisteren zei he....in het verleden behaalde resultaten bieden geen garantie voor de toekomst
Amarillo schreef op 6 augustus 2020 07:34 :
Je weet wat ik gisteren zei he....in het verleden behaalde resultaten bieden geen garantie voor de toekomst
Dat geldt natuurlijk ook voor jou met je opschepperij.
We kunnen het ook omdraaien...waarom dwaal jij hier nog rond terwijl je niet 1 aandeel bezit?? Beetje overal tegenaan schoppen, ouwe koeien uit de sloot halen, ouwe berichten spammen....niks te doen zeker??
Amarillo schreef op 6 augustus 2020 08:45 :
We kunnen het ook omdraaien...waarom dwaal jij hier nog rond terwijl je niet 1 aandeel bezit?? Beetje overal tegenaan schoppen, ouwe koeien uit de sloot halen, ouwe berichten spammen....niks te doen zeker??
Het is opvallend maar niet verbazingwekkend dat jij nooit ingaat op inhoudelijke zaken m.b.t. Esperite. Gelukkig kun je nog terecht in Benidorm, want daar kunnen ze altijd proppers gebruiken.
Gelukkig vetrouwd ridder blind op dubieuze geert..
Amarillo schreef op 10 augustus 2020 16:47 :
Gelukkig vetrouwd ridder blind op dubieuze geert..
Ik heb helemaal niks met Geert, zelfs geen abonnement.
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
CVC Capital Partners
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Indices
AEX
880,36
+0,17%
EUR/USD
1,0698
-0,12%
FTSE 100
8.157,42
+0,45%
Germany40^
17.955,90
+0,13%
Gold spot
2.299,51
+0,60%
NY-Nasdaq Composite
15.605,48
-0,33%
Stijgers
Dalers